Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Georgia Pepe"'
Autor:
Konstantinos Agiannitopoulos, Eirini Papadopoulou, Georgios N. Tsaousis, Georgia Pepe, Stavroula Kampouri, Mehmet Ali Kocdor, George Nasioulas
Publikováno v:
BMC Medical Genetics, Vol 20, Iss 1, Pp 1-4 (2019)
Abstract Background CHEK2 is involved in the DNA damage repair response Fanconi anemia (FA)-BRCA pathway. An increased risk for breast and other cancers has been documented in individuals who carry a single pathogenic CHEK2 variant. As for other gene
Externí odkaz:
https://doaj.org/article/9cd9b6a0109248969a8e2a424e37fa8e
Autor:
Georgios N. Tsaousis, Eirini Papadopoulou, Angela Apessos, Konstantinos Agiannitopoulos, Georgia Pepe, Stavroula Kampouri, Nikolaos Diamantopoulos, Theofanis Floros, Rodoniki Iosifidou, Ourania Katopodi, Anna Koumarianou, Christos Markopoulos, Konstantinos Papazisis, Vasileios Venizelos, Ioannis Xanthakis, Grigorios Xepapadakis, Eugeniu Banu, Dan Tudor Eniu, Serban Negru, Dana Lucia Stanculeanu, Andrei Ungureanu, Vahit Ozmen, Sualp Tansan, Mehmet Tekinel, Suayib Yalcin, George Nasioulas
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-19 (2019)
Abstract Background Hereditary cancer predisposition syndromes are responsible for approximately 5–10% of all diagnosed cancer cases. In the past, single-gene analysis of specific high risk genes was used for the determination of the genetic cause
Externí odkaz:
https://doaj.org/article/dc43f140d22c4f09805d95f871555460
Autor:
Konstantinos Agiannitopoulos, Eirini Papadopoulou, Georgios N. Tsaousis, Georgia Pepe, Stavroula Kampouri, Eleni Patsea, George Lypas, George Nasioulas
Publikováno v:
Molecular Genetics & Genomic Medicine, Vol 8, Iss 10, Pp n/a-n/a (2020)
Abstract Background Carriers with pathogenic variants in MSH2 have increased risk to develop colorectal, endometrium, ovarian, and other types of cancer. The PALB2 is associated with breast, ovarian, pancreatic, and prostate cancer. We describe the c
Externí odkaz:
https://doaj.org/article/2f71d7a46691488889c81edc5d993354
Autor:
Nikolaos Tsoulos, Konstantinos Agiannitopoulos, Georgia Pepe, Eirini Papadopoulou, Georgios N Tsaousis, Despina Apostolopoulou, Angeliki Meintani, Vassileios Venizelos, Christos Markopoulos, Rodoniki Iosifidou, Sofia Karageorgopoulou, Christos Christodoulou, Ioannis Natsiopoulos, Konstantinos Papazisis, Maria Vasilaki-Antonatou, Eleftherios Kabletsas, Amanta Psyrri, Stylianos Giassas, Dimitrios Ziogas, Efthalia Lalla, Anna Koumarianou, Christos Papadimitriou, Vahit Ozmen, Sualp Tansan, Kerim Kaban, Tahsin Ozatlı, Dan Tudor Eniu, Angelica Chiorean, Alexandru Blidaru, George Nasioulas
Publikováno v:
Cancer Research. 82:P2-09
Background: Breast cancer is the most frequently diagnosed cancer in women and about 10% of breast cancer cases are hereditary. BRCA1 and BRCA2 are the genes most frequently associated with Hereditary Breast Cancer, although there are numerous other
Autor:
ANGELA APESSOS, KONSTANTINOS AGIANNITOPOULOS, GEORGIA PEPE, GEORGIOS N. TSAOUSIS, PANAGIOTA PITTA, CHRYSANTHI BILI, LINA FLORENTIN, EMMANOUEL SALOUSTROS, ELEFTHERIOS KAMPLETSAS, DIMITRIOS TRYFONOPOULOS, NIKOLAOS TSOUKALAS, EVANGELOS BOURNAKIS, FLORA ZAGOURI, ATHANASSIOS KOTSAKIS, ANNA KOUMARIANOU, IPPOKRATIS KORANTZIS, IOANNIS BOUKOVINAS, GEORGE LYPAS, GEORGIOS FOUNTZILAS, VASILIKI MICHALAKI, SPYRIDON XYNOGALOS, HELENA LINARDOU, EIRINI PAPADOPOULOU, GEORGE NASIOULAS, VASSILIS GEORGOULIAS
Publikováno v:
Anticancer research. 42(12)
Male breast cancer (MBC) is a very rare disorder affecting approximately 1 in 833 men. Genetic predisposition is one of the most important risk factors of MBC with BRCA2 being the most commonly mutated gene in males diagnosed with breast cancer. Howe
Autor:
Eirini Papadopoulou, Georgia Pepe, Spiridon Konitsiotis, Maria Chondrogiorgi, Nikolaos Grigoriadis, Vasilios K. Kimiskidis, Georgios Tsivgoulis, Dimos D. Mitsikostas, Elisabeth Chroni, Eleni Domouzoglou, Georgios Tsaousis, Georgios Nasioulas
Publikováno v:
Journal of the Neurological Sciences. 447:120609
Autor:
Kerim Kaban, Sonia Maravelaki, Vahit Ozmen, Konstantinos Papazisis, Konstantinos Agiannitopoulos, Maria Vasilaki-Antonatou, Christos Markopoulos, Sofia Karageorgopoulou, Stavroula Kampouri, Vassileios Venizelos, Christos Christodoulou, Rodoniki Iosifidou, Georgios N. Tsaousis, Ioannis Natsiopoulos, Georgia Pepe, Athanassios Fassas, Eirini Papadopoulou, Dan Tudor Eniu, Sualp Tansan, George Nasioulas, Angelica Chiorean
Publikováno v:
Cancer Genomics Proteomics
Background Classification of splicing variants (SVs) in genes associated with hereditary cancer is often challenging. The aim of this study was to investigate the occurrence of SVs in hereditary cancer genes and the clinical utility of RNA analysis.
Autor:
GEORGIOS N. TSAOUSIS, EIRINI PAPADOPOULOU, KONSTANTINOS AGIANNITOPOULOS, GEORGIA PEPE, NIKOLAOS TSOULOS, IOANNIS BOUKOVINAS, THEOFANIS FLOROS, RODONIKI IOSIFIDOU, OURANIA KATOPODI, ANNA KOUMARIANOU, CHRISTOS MARKOPOULOS, KONSTANTINOS PAPAZISIS, VASILEIOS VENIZELOS, ACHILLEAS KAPSIMALIS, GRIGORIOS XEPAPADAKIS, AMANDA PSYRRI, EUGENIU BANU, DAN TUDOR ENIU, ALEXANDRU BLIDARU, DANA LUCIA STANCULEANU, ANDREI UNGUREANU, VAHIT OZMEN, SUALP TANSAN, MEHMET TEKINEL, SUAYIB YALCIN, GEORGE NASIOULAS
Publikováno v:
Cancer Genomics Proteomics
Background/Aim: The use of multi-gene panels for germline testing in breast cancer enables the estimation of cancer risk and guides risk-reducing management options. The aim of this study was to present data that demonstrate the different levels of a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17928cee2350acf8044f319ac3d2bec4
https://europepmc.org/articles/PMC8717958/
https://europepmc.org/articles/PMC8717958/
Autor:
Vahit Ozmen, Ahmet Caglayan, Kanay Yararbas, Cetin Ordu, Fatma Aktepe, Tolga Ozmen, Ahmet Ilgun, Gursel Soybir, Gul Alco, Georgios Tsaousis, Eirini Papadopoulou, Konstantinos Agiannitopoulos, Georgia Pepe, Stavroula Kampouri, George Nasioulas, Efe Sezgin, Atilla Soran
Publikováno v:
Oncology letters. 23(4)
Next-generation sequencing (NGS) technology is used to evaluate hereditary cancer risks of patients worldwide; however, information concerning the germline multigene mutational spectrum among patients with breast cancer (BC) with consanguineous marri
Autor:
Ourania Katopodi, George Nasioulas, Stavroula Kampouri, Georgia Pepe, Rodoniki Iosifidou, Dan Tudor Eniu, Eirini Papadopoulou, Anna Koumarianou, Christos Markopoulos, Mehmet Tekinel, Serban Negru, Ioannis Xanthakis, V. Venizelos, Grigorios Xepapadakis, Sualp Tansan, Vahit Ozmen, Konstantinos Papazisis, Suayib Yalcin, Georgios N. Tsaousis, Nikolaos Diamantopoulos, E Banu, Theofanis Floros, Dana Lucia Stanculeanu, Konstantinos Agiannitopoulos, A Ungureanu, Angela Apessos
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-19 (2019)
BMC Cancer
BMC Cancer
Background Hereditary cancer predisposition syndromes are responsible for approximately 5–10% of all diagnosed cancer cases. In the past, single-gene analysis of specific high risk genes was used for the determination of the genetic cause of cancer